The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Keating Laurie B. since year 2005.
The trader's CIK number is 1304930.
At the time of this reporting, Keating Laurie B. is the SVP and General Counsel of Millennium Pharmaceuticals Inc .
(stock ticker symbol MLNM).
See this page for all insider trading activities at Millennium Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Keating Laurie B. since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-03-11
MLNM
Millennium Pharmaceuticals Inc
Sale
6,784
12.82
86,970
2008-03-07
MLNM
Millennium Pharmaceuticals Inc
Sale
3,216
13.34
42,900
2008-02-29
MLNM
Millennium Pharmaceuticals Inc
Sale
4,075
13.67
55,725
2008-03-03
MLNM
Millennium Pharmaceuticals Inc
Sale
6,240
13.99
87,297
2008-01-04
MLNM
Millennium Pharmaceuticals Inc
Sale
5,281
14.85
78,422
2008-01-03
MLNM
Millennium Pharmaceuticals Inc
Sale
4,830
16.11
77,811
2007-12-06
MLNM
Millennium Pharmaceuticals Inc
Sale
1,716
15.18
26,048
2007-11-05
MLNM
Millennium Pharmaceuticals Inc
Option Exercise
25,000
8.41
210,250
2007-11-05
MLNM
Millennium Pharmaceuticals Inc
Sale
25,000
12.68
316,875
2007-03-20
MLNM
Millennium Pharmaceuticals Inc
Option Exercise
12,400
8.41
104,284
2007-03-20
MLNM
Millennium Pharmaceuticals Inc
Sale
12,400
11.00
136,400
2007-03-13
MLNM
Millennium Pharmaceuticals Inc
Option Exercise
19,000
8.41
159,790
2007-03-13
MLNM
Millennium Pharmaceuticals Inc
Sale
25,568
10.92
279,100
2007-02-12
MLNM
Millennium Pharmaceuticals Inc
Option Exercise
19,787
8.41
166,408
2007-02-12
MLNM
Millennium Pharmaceuticals Inc
Sale
29,469
11.29
332,632
2007-01-04
MLNM
Millennium Pharmaceuticals Inc
Sale
5,318
11.02
58,604
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Keating Laurie B.
(SVP and General Counsel of Millennium Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
